BIAF Stock Rises Post Q1 Earnings Despite Revenue Decline
Shares of bioAffinity Technologies, Inc. BIAF have risen 0.04% since the company reported its earnings for the quarter ended March 31, 2025, slightly lagging the broader market, as the S&P 500 Index rose 1.1% over the same period. However, the stock's longer-term performance has been notably weak, with a 54.7% decline over the past month compared to a robust 15.4% increase in the S&P 500.
For the first quarter of 2025, bioAffinity reported revenues of $1.9 million, down 22.9% from $2.4 million in the year-ago period. The decline was primarily due to changes in revenue contributions from patient service fees, histology services and medical director fees. Despite the top-line contraction, BIAF's net loss narrowed on a per-share basis to $0.16 compared with a net loss of $0.20 per share in the first quarter of 2024, though the absolute loss widened to $2.7 million from $1.9 million due to a higher share count. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Operating expenses increased 2.9% to $4.5 million from $4.4 million in the prior-year quarter. Direct costs and expenses declined 13.1% to $1.4 million from $1.6 million, and R&D expenses fell 6.7% to $367,386 from $393,639. However, clinical development expenses rose sharply from $48,960 to $138,353, reflecting ongoing investments in bioAffinity's pivotal trial strategy. Selling, general and administrative expenses increased 12.2% to $2.5 million from $2.2 million, as the company scaled its commercialization team for CyPath Lung.
Sales of bioAffinity's flagship diagnostic, CyPath Lung, surged 276% year over year, reflecting growing market acceptance and operational scaling following the test's 2024 beta launch in Texas. The company emphasized strong demand during the quarter, supported by more than 600 tests delivered in 2024 and continued momentum into 2025. Management attributed the performance to the test's clinical utility, including its ability to detect early-stage lung cancer and prevent unnecessary invasive procedures.
The sharp revenue decline appears at odds with the CyPath Lung sales spike, likely indicating a strategic pivot away from low-margin services. This aligns with management's decision to discontinue select pathology services and implement cost-cutting measures expected to save approximately $3.8 million annually. These actions are designed to improve profitability and focus resources on high-margin diagnostics.
bioAffinity Technologies, Inc. price-consensus-eps-surprise-chart | bioAffinity Technologies, Inc. Quote
CEO Maria Zannes highlighted bioAffinity's operational progress and strategic direction in her remarks. She pointed to a clear focus on commercial execution, including targeted labor reductions and operational changes at the company's subsidiary lab. These efforts are aimed at supporting CyPath Lung's growth while improving the overall cost structure.
Zannes also emphasized recent enhancements in CyPath Lung's test processing. Specifically, post-quarter improvements increased data acquisition throughput by 50% and reduced per-test cost by more than 25%, materially enhancing scalability and profitability without compromising clinical performance.
bioAffinity ended the quarter with $0.4 million in cash, down from $1.1 million as of Dec. 31, 2024. However, the company has since bolstered its liquidity position, raising $1.4 million through warrant exercises in February and an additional $3.3 million via a public offering in May. These capital raises are expected to support commercialization efforts and ongoing clinical development.
bioAffinity did not provide forward-looking financial guidance. However, qualitative commentary suggested a continued strategic pivot toward diagnostics and ongoing expansion of CyPath Lung's market presence.
In addition to financial and operational updates, bioAffinity reported progress in strengthening its intellectual property portfolio. During the quarter, the company received acceptance of a patent application from the Australian Patent Office for CyPath Lung. This development enhances the test's international commercialization potential and broadens BIAF's global IP footprint.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
bioAffinity Technologies, Inc. (BIAF): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Wall Street's calling it a 'shattered illusion' as Trump launches strikes on Iran
Wall Street's calling it a 'shattered illusion' as Trump launches strikes on Iran originally appeared on TheStreet. The U.S. bombing of Iran's nuclear sites has sent shockwaves through Wall Street, with investors and billionaires reacting to what many now see as a turning point in global markets — and geopolitics. President Donald Trump confirmed late Saturday that the U.S. had carried out airstrikes on three key nuclear facilities in Fordow, Natanz and Isfahan. He called it a 'spectacular military success,' warning Iran that further retaliation would be met with even greater force. 'This shatters the illusion of containment,' wrote SPI Asset Management's Stephen Innes. 'What was a regional proxy conflict is now a high-stakes, U.S.-driven air war targeting WMD infrastructure — with unpredictable spillovers across energy markets, global shipping lanes, and risk sentiment.' Markets are still closed for the weekend, but early signals point to turbulence. Oil futures are expected to spike when they open Sunday night, with concerns Iran could retaliate by closing the Strait of Hormuz — a vital chokepoint for global oil and gas supplies. James Bambino of S&P Global warned that while global oil reserves are sufficient for now, any disruption in shipping could spark inflation. 'The world has enough oil… so long as the Strait of Hormuz remains open — and we expect that it will,' he wrote. Meanwhile, crypto markets have already started reacting. Bitcoin dropped slightly to $102,800, while Ethereum is down over 5%. Altcoins followed suit, as investors rotated to stable assets amid the uncertainty. 'All were down,' one CoinGecko analyst noted, describing it as a broad sell-off triggered by geopolitical stress. Billionaires also weighed in. Hedge fund manager Bill Ackman posted on X, 'Thank you to our great military for its superb execution on ridding Iran of its nuclear threat… To state the obvious, Donald Trump's actions tonight are a lot better than relying on the IRGC's 'commitment' to not develop nuclear weapons.' Jason Calacanis was blunt, 'Five months into Trump's term, we're at war.' With stocks likely to open volatile and oil expected to climb, Wall Street is bracing for a week shaped by geopolitics, and possibly the start of something bigger. After weeks of mounting tension, the U.S. finally bombed Iranian nuclear sites — and Polymarket traders had seen it coming. Just days before the first missiles dropped, Polymarket, a crypto-based prediction market showed a 60% chance that the U.S. would launch a military strike on Iran by June 30. That number later dipped to 40% after a temporary White House de-escalation update. But as it turns out, traders betting on 'Yes' were spot on. With over $29 million wagered, it was one of the most closely-watched geopolitical bets of the year on Polymarket. Wall Street's calling it a 'shattered illusion' as Trump launches strikes on Iran first appeared on TheStreet on Jun 22, 2025 This story was originally reported by TheStreet on Jun 22, 2025, where it first appeared. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Oil markets brace for shock after US attack on Iran
Oil prices are expected to jump in reaction to the US strikes on Iran's nuclear facilities, but the long-term impact may be muted, experts said. Oil prices have risen since Israel began attacking Iran, but supplies have remained steady. 'The world has enough oil,' S&P analysts wrote. Still, if Iran follows through with a threat to close the Strait of Hormuz, a key oil shipping route, it would severely curb supply and disrupt global markets. Such a move however, would mostly harm Tehran's ally China, which buys the vast majority of Iranian oil. Investors are also bracing for a knee-jerk stock selloff Monday, with analysts warning that surging oil prices and further escalation could trigger an extended rout. — J.D. Capelouto Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
USA Today
3 hours ago
- USA Today
How investing $33 a day could make you a millionaire by retirement
Most of us would love to be a millionaire, and many of us think, often correctly, that if we want to have a comfortable retirement, we'd better be a millionaire by the time we retire. (For many others, $1 million isn't enough -- much depends on where you live and how you live.) Here's a look at how you might become a millionaire by retirement by saving and investing just $33 per day. How $33 per day can get you to $1 million − or more An article like this can be very eye-opening and instructive, but it's hard to offer one table that applies equally well to everyone. Let's start with the table − and I'll add a lot of caveats and considerations after it. Investing $12,000 Annually for: Growing at 8% Annually Growing at 10% Annually Growing at 12% Annually Five years $76,032 $80,587 $85,382 10 years $187,746 $210,374 $235,855 15 years $351,892 $419,397 $501,039 20 years $593,076 $756,030 $968,385 25 years $947,452 $1,298,181 $1,792,007 30 years $1,468,150 $2,171,321 $3,243,511 35 years $2,233,226 $3,577,522 $5,801,557 40 years $3,357,372 $5,842,222 $10,309,707 I used several growth rates in that table, because the stock market can be somewhat unpredictable. Over many decades, the stock market has averaged annual returns of close to 10%. But over your investing period, it might average more -- or less. So for best results, go ahead and aim and hope for high returns, but prepare for lower ones, just in case. How much per day do you need to save and invest? You'll notice that per the table, it may take you 20 or 25 years to become a millionaire, saving and investing $33 per day, on average. That might not be good enough, if you're, say, 55 years old already. So check out the table, detailing how much you need to save to retire with $1 million -- if you want to retire at 65 and your money grows at 8% annually: Starting Age Monthly Savings Needed Daily Savings Needed 25 $325 $11 30 $485 $16 35 $740 $24 40 $1,140 $37 45 $1,825 $60 50 $3,070 $101 55 $5,760 $189 How should you invest your money? So now that you have a rough idea of how much you should be saving and investing, how should you be investing? Well, arguably the simplest, most effective strategy is just to invest in a low-fee, broad-market index fund, such as one that tracks the S&P 500. Since the S&P 500 has averaged annual returns close to 10% (ignoring inflation) over long periods, you have a fighting chance over your investment period to achieve an average annual gain of perhaps 8% or 10% − or possibly more. Index funds make investing easy, with an S&P 500 index fund, for example, such as the Vanguard S&P 500 ETF, instantly plunking you into 500 of America's biggest companies. If you can stomach some more risk, though, perhaps park some of your dollars in some fast-growing ETFs − though they can be more volatile. However you do it, be sure that you have a solid retirement plan and that you're sticking with it, saving and investing for a comfortable future. Selena Maranjian has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Vanguard S&P 500 ETF. The Motley Fool has a disclosure policy. The Motley Fool is a USA TODAY content partner offering financial news, analysis and commentary designed to help people take control of their financial lives. Its content is produced independently of USA TODAY. The $23,760 Social Security bonus most retirees completely overlook Offer from the Motley Fool: If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets"could help ensure a boost in your retirement income. One easy trick could pay you as much as $23,760 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. JoinStock Advisorto learn more about these strategies. View the "Social Security secrets" »
